Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Nodthera patents NLRP3 inflammasome inhibitors

Feb. 28, 2019

Toll-like receptor 7/8/9 antagonists discovered at Bristol-Myers Squibb

Feb. 26, 2019

Bristol-Myers Squibb identifies TLR7/8/9 antagonists

Feb. 22, 2019

EZH2 inhibitors may be a means of treating scleroderma

Feb. 20, 2019

Topline results from Japanese confirmatory phase III study of ONO-5704 in knee osteoarthritis

Feb. 19, 2019

FASST study of lanifibranor in diffuse cutaneous systemic sclerosis does not meet primary endpoint

Feb. 19, 2019

Grant to support phase II development of AKL's APPA for osteoarthritis

Feb. 18, 2019

Nimbus Lakshmi discloses new TYK2 inhibitors

Feb. 14, 2019

Misplaced energy turns T cells proinflammatory

Feb. 7, 2019

Evidence of molecular mechanism of DZ-2002 on glomerulonephritis in SLE

Feb. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...